Cost of care in EGFR mutant versus wild-type non-small cell lung cancer.

被引：0
|
作者：
Vusqa, Urwat Til
Asawa, Palash
Miller, Katherine
Sethi, Ashish
Rodriguez, Robin Raquel
Friday, Andrew
Finley, Gene Grant
机构：
[1] Allegheny Gen Hosp, Pittsburgh, PA USA
[2] Allegheny Hlth Network, Internal Med, Pittsburgh, PA USA
[3] Allegheny Gen Hosp, Dept Hematol & Oncol, Pittsburgh, PA USA
[4] Allegheny Hlth Network, Pittsburgh, PA USA
[5] AGH, Allegheny Hlth Network, Canc Inst, Pittsburgh, PA USA
[6] AHN, Pittsburgh, PA USA
[7] Alle Kiski Canc Ctr, Natrona Heights, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21084
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EGFR tyrosine kinase inhibitor in advanced non-small cell lung cancer with wild-type EGFR
    Wang, Z.
    Wu, Y. L.
    Yang, J.
    Wang, B.
    Huang, Y.
    Zhou, Q.
    Xu, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [2] A study of EGFR wild-type non-small cell lung cancer ALK genetic mutation
    Wang, Shoufeng
    Mao, Naiquan
    Zuo, Chuantian
    Pan, Hong
    Xie, Tong
    Huang, Yaoyuan
    Pan, Qi
    Wu, Junwei
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 976 - 980
  • [3] Examination of the importance of RUNX category in EGFR wild-type non-small cell lung cancer
    Kobayakawa, Atsushi
    Takeda, Kanako
    Masuda, Tatuya
    Yanagida, Yohei
    Obi, Natsuno
    Sakuramoto, Naoya
    Hada, Asuka
    Horiuchi, Ayaka
    Takeda, Mizuho
    Sasaki, Asami
    Matsuo, Hidemasa
    Sugiyama, Hiroshi
    Adachi, Souichi
    Kamikubo, Yasuhiko
    [J]. CANCER SCIENCE, 2021, 112 : 445 - 445
  • [4] A multifunctional nanotheranostic agent potentiates erlotinib to EGFR wild-type non-small cell lung cancer
    Wang, Duo
    Zhou, Jun
    Fang, Weimin
    Huang, Cuiqing
    Chen, Zerong
    Fan, Meng
    Zhang, Ming-Rong
    Xiao, Zeyu
    Hu, Kuan
    Luo, Liangping
    [J]. BIOACTIVE MATERIALS, 2022, 13 : 312 - 323
  • [5] Neurological death in patients with EGFR-mutant non-small cell lung cancer.
    Ramotar, Matthew
    Barnes, Sierra
    Doherty, Mark
    Shultz, David Benjamin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non-small cell lung cancer
    Felip, Enriqueta
    Metro, Giulio
    Tan, Daniel S. W.
    Wolf, Juergen
    Mark, Michael
    Boyer, Michael
    Hughes, Brett G. M.
    Bearz, Alessandra
    Moro-Sibilot, Denis
    Le, Xiuning
    Puente, Javier
    Massuti, Bartomeu
    Tiedt, Ralph
    Wang, Yingying
    Xu, Chao
    Mardjuadi, Feby I.
    Cobo, Manuel
    [J]. LUNG CANCER, 2024, 192
  • [7] Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells
    Li, Amin
    Cao, Weiya
    Liu, Xueke
    Zhang, Yinci
    Ma, Yongfang
    Xu, Ruyue
    Zhang, Rongbo
    Liu, Xinkuang
    Zhou, Shuping
    Wang, Ruikai
    Liu, Jiachang
    Tang, Xiaolong
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (07) : 1737 - 1749
  • [8] Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells
    Amin Li
    Weiya Cao
    Xueke Liu
    Yinci Zhang
    Yongfang Ma
    Ruyue Xu
    Rongbo Zhang
    Xinkuang Liu
    Shuping Zhou
    Ruikai Wang
    Jiachang Liu
    Xiaolong Tang
    [J]. Journal of Cancer Research and Clinical Oncology, 2020, 146 : 1737 - 1749
  • [9] Sensitization of EGFR Wild-Type Non-Small Cell Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitor Erlotinib
    Raimbourg, Judith
    Joalland, Marie-Pierre
    Cabart, Mathilde
    de Plater, Ludmilla
    Bouquet, Fanny
    Savina, Ariel
    Decaudin, Didier
    Bennouna, Jaafar
    Vallette, Francois M.
    Lalier, Lisenn
    [J]. MOLECULAR CANCER THERAPEUTICS, 2017, 16 (08) : 1634 - 1644
  • [10] Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer.
    Wu, Shaocong
    Luo, Min
    To, Kenneth K.
    Zhang, Jianye
    Su, Chaoyue
    Zhang, Hong
    An, Sainan
    Wang, Fang
    Chen, Da
    Fu, Li-Wu
    [J]. CANCER RESEARCH, 2021, 81 (13)
12345